Baidu
map

Int J Oral Surg:低血压麻醉不是正颌术后单眼失明的主要原因

2018-01-07 MedSci MedSci原创

非眼部手术中的围手术期视力丧失是多种原因所致的罕见且破坏性强的并发症。

非眼部手术中的围手术期视力丧失是多种原因所致的罕见且破坏性强的并发症。视觉系统的任何部分都可能涉及,一些作者试图将这种并发症与用于控制术中出血的低血压麻醉技术相关联。我们研究了一名正颌手术后单侧失明的患者。经过对类似病例的回顾,我们发现Le fort I截骨术中产生的力的传递与并发症有关。作者所在医院在这种截骨技术中经常使用弯曲的骨切开器进行翼上颌骨的分离,该作用力通过蝶骨传输是视神经及其血管结构间接损伤导致神经病变和失明的主要原因。由于减少眼压灌注,降压麻醉在某些特定病例中肯定会导致短暂的局部缺血。

原始出处:

A. Rodriguez-Navarro, et al. Unilateral blindness after orthognathic surgery: hypotensive anaesthesia is not the primary cause. International Journal of Oral and Maxillofacial Surgery. 2018 January. doi:http://dx.doi.org/10.1016/j.ijom.2017.07.006

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2020333, encodeId=a71c2020333dc, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Tue Aug 28 18:04:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367359, encodeId=d95f136e3599e, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Jan 09 06:04:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276410, encodeId=2ac92e6410c6, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sun Jan 07 16:24:20 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276396, encodeId=bad42e639662, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jan 07 15:19:45 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2018-08-28 小几洁
  2. [GetPortalCommentsPageByObjectIdResponse(id=2020333, encodeId=a71c2020333dc, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Tue Aug 28 18:04:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367359, encodeId=d95f136e3599e, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Jan 09 06:04:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276410, encodeId=2ac92e6410c6, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sun Jan 07 16:24:20 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276396, encodeId=bad42e639662, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jan 07 15:19:45 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2020333, encodeId=a71c2020333dc, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Tue Aug 28 18:04:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367359, encodeId=d95f136e3599e, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Jan 09 06:04:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276410, encodeId=2ac92e6410c6, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sun Jan 07 16:24:20 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276396, encodeId=bad42e639662, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jan 07 15:19:45 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2018-01-07 三生有幸9135

    学习一下谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2020333, encodeId=a71c2020333dc, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Tue Aug 28 18:04:00 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367359, encodeId=d95f136e3599e, content=<a href='/topic/show?id=f4012634656' target=_blank style='color:#2F92EE;'>#低血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26346, encryptionId=f4012634656, topicName=低血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Jan 09 06:04:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276410, encodeId=2ac92e6410c6, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sun Jan 07 16:24:20 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276396, encodeId=bad42e639662, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jan 07 15:19:45 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2018-01-07 1e0f8808m18(暂无匿称)

    学习了.谢谢分享.

    0

相关资讯

Angew Chem Int Ed:抗肿瘤抗生素生物合成研究中发现的一种新奇的自抗性机制

结构独特、活性显着的天然产物是大自然进化的结果,而要合成这些高活性化合物同时又要避免其对宿主可能造成的自身伤害是关键前提之一。为此宿主生物进化出多种自抗性保护途径:如外排泵将化合物排出细胞外,对化合物减毒的化学修饰或屏蔽,针对作用靶体的多拷贝、修饰或修复等。最近中国科学院上海有机化学研究所生命有机化学国家重点实验室唐功利课题组在抗肿瘤抗生素谷田霉素的生物合成研究中发现了一类独特的糖基水解酶,其生理

Int J Oncol:阻断缺氧调控的TMPRSS4治疗肿瘤

早期研究证实TMPRSS4的过度表达与胰腺癌、大肠癌和甲状腺癌等类型癌症的发生发展有关。TMPRSS4是一种细胞表面跨膜丝氨酸蛋白酶,这一蛋白的表达对肿瘤细胞的迁移和转移有作用。 过去,有几项研究探讨了TMPRSS4基因表达水平以及蛋白产物。最近刊登在Int J Oncol杂志上的一则研究中,研究人员用定量RT-PCR和蛋白质染色来评估原发性非小细胞肺癌(NSCLC)组织和肺肿瘤细胞株中TMPR

Kidney. Int:宁光等发现塑料用品易引发白蛋白尿

近期,上海交通大学医学院附属瑞金医院内分泌代谢科宁光教授等开展的一项研究表明,长期接触双酚A 可致低水平白蛋白尿(尿白蛋白肌酐比值为9.71~29.9 mg/g)风险增加。相关论文发表在Kidney International杂志上。 双酚A 是一种广泛用于塑料制品行业的工业化学物质,常被用来生产聚碳酸酯塑料和环氧树脂,水瓶和很多食品容器中均含有双酚A。 该研究纳入上海3455 例年龄≥ 40

Int J Oral Max Surg:术前CT预测下颌第三磨牙拔除时下牙槽神经损伤的风险

实验使用计算机断层扫描(CT)图像评估第三磨牙拔除时综合评估的临床有用性。

Int J Oncol:川芎嗪靶向COX-2抑制肿瘤转移

环氧化酶(cyclooxygenase,COX)是参与花生四烯酸的环氧酶代谢途径中的限速酶,可催化花生四烯酸转化为前列腺素(prostaglandins,PGs)。近年来研究显示,COX-2在一些肿瘤中存在过度表达现象,提示COX-2可能与肿瘤的发生发展密切相关。 环氧合酶(COX)-2在肺癌中起着重要作用,是肺癌侵袭和转移的关键因素。传统中药川芎有效成分川芎嗪(TMP),历来用于治疗神经、血管

Baidu
map
Baidu
map
Baidu
map